Scarica l'app Stockscreener
7.99
1.36%
-0.11
Journey Medical Corp Borsa (DERM) Ultime notizie
Buyout Rumor: Can Journey Medical Corporation be recession proofJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - baoquankhu1.vn
Insurer Seeks To Cap Coverage In $3M Medical Transport Row - Law360
Essex Investment Management Co. LLC Acquires 125,818 Shares of Journey Medical Corporation $DERM - MarketBeat
Tetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica - GlobeNewswire Inc.
Journey Medical Corporation (NASDAQ:DERM) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Journey Medical (NASDAQ:DERM) Shares Down 3.7%Here's What Happened - MarketBeat
Patient journey goes digital at Ewha Womans Seoul Hospital - Healthcare IT News
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target By Investing.com - Investing.com South Africa
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target - Investing.com
10 Best Travel Insurance Companies For 2026 - Forbes
Will Journey Medical Corporation benefit from geopolitical trendsPortfolio Update Summary & Growth Oriented Trading Recommendations - mfd.ru
Value Recap: Can Journey Medical Corporation reach all time highs this year - baoquankhu1.vn
Risk Analysis: Is DUKPRA impacted by rising ratesMarket Risk Report & Community Supported Trade Ideas - baoquankhu1.vn
CVS Health Corp.: How a Pharmacy Giant Is Rebooting Itself as a Healthcare Platform - AD HOC NEWS
Journey Medical Corp entered into sales agreement to offer and sell up to 3.75 million shares of common stock - marketscreener.com
Journey Medical Corp Entered Into Sales Agreement To Offer And Sell Up To 3.75 Million Shares Of Common Stock - TradingView
Published on: 2026-01-20 22:55:08 - baoquankhu1.vn
Does Autonomix Medical Inc meet Warren Buffetts criteriaJuly 2025 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Published on: 2026-01-19 20:20:55 - baoquankhu1.vn
Journey Medical Corp: Small-Cap Dermatology Stock Walks a Tightrope Between Turnaround Hopes and Vol - AD HOC NEWS
Is Cerus Corporation being accumulated by smart money2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of “Hold” by Analysts - Defense World
Journey Medical Files $150 Million Mixed Shelf - marketscreener.com
Journey Medical (NASDAQ:DERM) Trading 3.4% HigherHere's What Happened - MarketBeat
WebMD Launches Embody -- A Whole-Self Health, Weight Loss, and Weight Management Platform - The AI Journal
Early ZYCUBO treatment cut death risk nearly 80% in children with Menkes - Stock Titan
CVS Health Corp.: How a Pharmacy Giant Is Re?Engineering the Front Door to U.S. Healthcare - AD HOC NEWS
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome Data - MSN
Will Journey Medical Corporation stock gain from government policiesJuly 2025 Retail & AI Enhanced Trading Signals - Улправда
Is Microbot Medical Inc. (CY9D) stock vulnerable to rate hikesWeekly Stock Report & Weekly High Return Opportunities - ulpravda.ru
Can Tenon Medical Inc. Equity Warrant stock hit record highs againJuly 2025 Retail & Weekly Hot Stock Watchlists - Улправда
Why Orthofix Medical Inc. (OM2) stock is upgraded to buyAnalyst Upgrade & Safe Capital Growth Tips - Улправда
IMG Opens Applications for 2026 Spring Semester 'Student Journey Scholarship' - Yahoo Finance
Best Medical Travel Insurance Companies of 2026 - U.S. News & World Report
9 Best Performing Micro Cap Stocks in 2025 - Insider Monkey
Trending At The PTAB: The Journey Of IPR Institution In 2025 - Law360
The Truth About Journey Medical Corp (DERM): Tiny Stock, Big Drama – Is It Worth the Hype? - AD HOC NEWS
Layoff Tracker: Nido Will Close Following Lead Candidate’s Disappointing Phase II Results - BioSpace
Fourteen new option listings on November 12th - MSN
Public companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33% - Yahoo Finance
Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Earnings Beat: Why Profound Medical Corp stock attracts high net worth investorsMarket Trend Review & Risk Controlled Swing Trade Alerts - moha.gov.vn
Aug Weekly: Can Quipt Home Medical Corp. stock reach $100 price targetPortfolio Return Report & Reliable Entry Point Alerts - ulpravda.ru
Journey Medical (NASDAQ:DERM) Trading 2.1% Higher – What’s Next? - Defense World
How Orthofix Medical Inc. stock performs in interest rate cycles2025 Volatility Report & Accurate Entry and Exit Point Alerts - ulpravda.ru
Sheets Smith Investment Management Invests $946,000 in Journey Medical Corporation $DERM - MarketBeat
Is Journey Medical Corporation stock cheap at current valuationWeekly Trade Review & Target Return Focused Stock Picks - Улправда
Journey Medical (NASDAQ:DERM) Trading 2.1% HigherWhat's Next? - MarketBeat
How Journey Medical Corporation stock benefits from tech adoptionWeekly Investment Summary & Smart Allocation Stock Tips - Улправда
Can Zhejiang Taimei Medical Technology Co. Ltd. (A2V) stock ride next bull market cycleMarket Sentiment Summary & Entry Point Confirmation Alerts - Улправда
Can Unidoc Health Corp. (L7T) stock beat analyst consensusJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - Улправда
Is Journey Medical Corporation stock a buy on dipsEarnings Miss & Technical Analysis for Trade Confirmation - Улправда
How analysts rate Quipt Home Medical Corp. stock todayWeekly Gains Report & Accurate Trade Setup Notifications - Улправда
Fortress Biotech (Nasdaq: FBIO): FDA accepts Class 1 resubmission, CUTX-101 PDUFA Jan. 14, 2026 - Stock Titan
Journey Medical announces results from phase 1 trial of DFD-29 - MSN
1.21%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):